Cargando…
The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) Affects Tissue Non-specific Alkaline Phosphatase (TNAP) Activities
ANKH (human homolog of progressive ankylosis) regulates inorganic pyrophosphate (PPi) transport. Dominant ANKH mutations were detected in at least five multiplex families with calcium pyrophosphate dihydrate crystal deposition disease (CPPPD). The objective of this study is to assess the functional...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577949/ https://www.ncbi.nlm.nih.gov/pubmed/19088867 http://dx.doi.org/10.2174/1874312900802010023 |
_version_ | 1782160520581742592 |
---|---|
author | Wang, John Tsui, Hing Wo Beier, Frank Pritzker, Kenneth P.H. Inman, Robert D. Tsui, Florence W.L. |
author_facet | Wang, John Tsui, Hing Wo Beier, Frank Pritzker, Kenneth P.H. Inman, Robert D. Tsui, Florence W.L. |
author_sort | Wang, John |
collection | PubMed |
description | ANKH (human homolog of progressive ankylosis) regulates inorganic pyrophosphate (PPi) transport. Dominant ANKH mutations were detected in at least five multiplex families with calcium pyrophosphate dihydrate crystal deposition disease (CPPPD). The objective of this study is to assess the functional consequences of one CPPDD-associated ANKH mutation (ΔE490) in chondrogenic ATDC5 cells. Stable ATDC5 transfectants bearing myc-tagged constructs of wild-type ANKH, mutant ANKH (ΔE490) and neo controls were generated. Upon ITS (insulin, transferrin and selenium) induction, expression of chondrocyte markers including alkaline phosphatase activity in the various transfectants was assessed. The ANKH ΔE490- transfectants had low alkaline phosphatase activities throughout ITS treatment due to lower TNAP protein expression and the presence of intracellular low-molecular-weight inhibitors. Our results suggest that the interplay of ANKH and TNAP activities is tightly regulated. |
format | Text |
id | pubmed-2577949 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Bentham Science Publishers Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-25779492008-12-16 The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) Affects Tissue Non-specific Alkaline Phosphatase (TNAP) Activities Wang, John Tsui, Hing Wo Beier, Frank Pritzker, Kenneth P.H. Inman, Robert D. Tsui, Florence W.L. Open Rheumatol J Article ANKH (human homolog of progressive ankylosis) regulates inorganic pyrophosphate (PPi) transport. Dominant ANKH mutations were detected in at least five multiplex families with calcium pyrophosphate dihydrate crystal deposition disease (CPPPD). The objective of this study is to assess the functional consequences of one CPPDD-associated ANKH mutation (ΔE490) in chondrogenic ATDC5 cells. Stable ATDC5 transfectants bearing myc-tagged constructs of wild-type ANKH, mutant ANKH (ΔE490) and neo controls were generated. Upon ITS (insulin, transferrin and selenium) induction, expression of chondrocyte markers including alkaline phosphatase activity in the various transfectants was assessed. The ANKH ΔE490- transfectants had low alkaline phosphatase activities throughout ITS treatment due to lower TNAP protein expression and the presence of intracellular low-molecular-weight inhibitors. Our results suggest that the interplay of ANKH and TNAP activities is tightly regulated. Bentham Science Publishers Ltd. 2008-04-10 /pmc/articles/PMC2577949/ /pubmed/19088867 http://dx.doi.org/10.2174/1874312900802010023 Text en Bentham Science Publishers Ltd. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/), which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article Wang, John Tsui, Hing Wo Beier, Frank Pritzker, Kenneth P.H. Inman, Robert D. Tsui, Florence W.L. The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) Affects Tissue Non-specific Alkaline Phosphatase (TNAP) Activities |
title | The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) Affects Tissue Non-specific Alkaline Phosphatase (TNAP) Activities |
title_full | The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) Affects Tissue Non-specific Alkaline Phosphatase (TNAP) Activities |
title_fullStr | The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) Affects Tissue Non-specific Alkaline Phosphatase (TNAP) Activities |
title_full_unstemmed | The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) Affects Tissue Non-specific Alkaline Phosphatase (TNAP) Activities |
title_short | The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) Affects Tissue Non-specific Alkaline Phosphatase (TNAP) Activities |
title_sort | ankh δe490mutation in calcium pyrophosphate dihydrate crystal deposition disease (cppdd) affects tissue non-specific alkaline phosphatase (tnap) activities |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577949/ https://www.ncbi.nlm.nih.gov/pubmed/19088867 http://dx.doi.org/10.2174/1874312900802010023 |
work_keys_str_mv | AT wangjohn theankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities AT tsuihingwo theankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities AT beierfrank theankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities AT pritzkerkennethph theankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities AT inmanrobertd theankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities AT tsuiflorencewl theankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities AT wangjohn ankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities AT tsuihingwo ankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities AT beierfrank ankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities AT pritzkerkennethph ankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities AT inmanrobertd ankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities AT tsuiflorencewl ankhde490mutationincalciumpyrophosphatedihydratecrystaldepositiondiseasecppddaffectstissuenonspecificalkalinephosphatasetnapactivities |